You are hereEvents
The Economic Burden Of Asthma (EBA) Study: A Summary Of Findings On Burden Of Asthma In BC
Asthma is one of the most common chronic diseases in Canada and worldwide. Despite this, not much is known about the economic and humanistic burden of asthma. To fill this evidence gap, we launched the Economic Burden of Asthma (EBA, 2010-2014) Study, a prospective longitudinal study of adolescents and adults with self-reported physician diagnosis of asthma in BC. We have recently submitted the 10th manuscript from this work. In many different aspects, these results update the outdated estimates of the burden of asthma and provide novel insights, in particular on the 'preventable burden' that is associated with identifiable care gaps in asthma in the Province. In this presentation, we will review the design of the EBA study and summarize its findings. The learning objectives include:
- To describe various aspects of the socio-economic burden of a disease such as direct costs, indirect costs, and impaired quality of life
- To distinguish the concept of 'preventable burden' as a more policy-relevant aspect of the burden of a disease compared with the conventional definition of burden
- To recognize the extent of the preventable burden of asthma in BC
C2E2 Rounds are presented Mondays from 12:00 pm to 1:00 pm in room 700 of the VGH Research Pavilion, 828 West 10th Avenue, Vancouver, BC.